A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma
一项针对晚期透明细胞肾细胞癌患者的 HIF-2α 抑制剂 DFF332 的 I 期剂量递增研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2618
Pal, Sumanta K; Bernard-Tessier, Alice; Grell, Peter; Gao, Xin; Kotecha, Ritesh R; Picus, Joel; de Braud, Filippo; Takahashi, Shunji; Wong, Alvin; Suárez, Cristina; Otero, Javier A; Kundamal, Nicole; Yang, Xin; Sharaby, Sherif; Roy, Mike; Barzaghi-Rinaudo, Patrizia; Tannir, Nizar M